In Vitro Diagnostics (IVD) include reagents, instruments, and systems intended for use in the diagnosis of disease or other conditions, including the determination of the state of health, in order to treat or prevent disease. The reagents, instruments and systems are used in the collection, preparation, and examination of specimens taken from the human body. This includes Cardiac Disease, Hematological Disorders, Hormonal Disorders, Metabolic Disorder, Infectious Disease, IVD Analyzers, Oncology and Reproductive Health Diagnostics. Cytomegalovirus (CMV) Tests are used for the detection of CMV. It is a common virus that is part of the herpesvirus family and can cause disease in people of all ages. GlobalData uses proprietary data and analytics to provide a comprehensive report on the cytomegalovirus (cmv) tests devices market, including market shares of different players within China. Buy the latest report here.
In 2023, GlobalData’s Market Model methodology determined that the leading player in the cytomegalovirus (cmv) tests market in China was F. Hoffmann-La Roche followed by DiaSorin, Abbott Laboratories, Qiagen, Quidelortho, Siemens Healthineers, Danaher, bioMerieux, Bio-Rad Laboratories, Merck, Trinity Biotech, Altona Diagnostic, WerfenLife, American Master Tech Scientific and JSR.
CMV infections are most prevalent in pregnant women, immunocompromised patients, and infants. The tests carried out in laboratories are considered. The CMV Test includes Cytomegalovirus (CMV) Enzyme Immuno Assay/Enzyme Linked Immunosorbent Assay (EIA/ELISA) Tests, Cytomegalovirus (CMV) Nucleic Acid Amplification Tests (NAATs), and Other Cytomegalovirus (CMV) Tests include shell vials, antigenemia, immunohistochemistry, immunofluorescence, latex agglutination, and culture assays.
The value of the cytomegalovirus (cmv) tests devices market within China was expected to be over $1m in 2023.
For the latest complete market share analysis of cytomegalovirus (cmv) tests device market in China, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.